Last updated 2026-08-06
Total raised
—
Stage
—
Founded
2016
Headcount
—
HQ
Haifa, Israel
Sector
Biotechnology
Registrar ID: 515391670 (CanCuRX)
About
CanCuRX is a startup founded by Carmel (University of Haifa's economic company) and researchers from the University of Haifa. It is developing a novel cancer treatment that utilizes extracts of Cyathus striatus mushrooms to reduce tumors in animals without damaging healthy tissues. CanCuRX has partnered with the Israeli biomedical company Cannabotech to develop plant-based cancer botanical drugs based on fungal extracts.
Offices
Haifa, Israel · HQ / main office
Q&A
- What is CanCuRX's primary focus?
- CanCuRX is developing plant-based cancer botanical drugs based on fungal extracts.
- Where is CanCuRX headquartered?
- CanCuRX is headquartered in Haifa, Israel.
- What is the core technology behind CanCuRX's cancer treatment?
- CanCuRX utilizes extracts of Cyathus striatus mushrooms to reduce tumors in animals without damaging healthy tissues.
- Who founded CanCuRX?
- CanCuRX was founded by Carmel (University of Haifa's economic company) and researchers from the University of Haifa.
- Has CanCuRX formed any strategic partnerships?
- CanCuRX has partnered with the Israeli biomedical company Cannabotech to develop plant-based cancer botanical drugs based on fungal extracts.
Sectors & technology
Primary sector
Biotechnology
Technologies
Target customers
Business model
B2B
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Legal name | CanCuRX |
|---|---|
| Founded | 2016 |
Radar intelligence
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515391670 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2016-02-29 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | שד אבא חושי 0 חיפה |